OSCR
Overvalued by 203.6% based on the discounted cash flow analysis.
Market cap | $4.65 Billion |
---|---|
Enterprise Value | $2.71 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.11 |
Beta | 1.73 |
Outstanding Shares | 251,279,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 43.23 |
---|---|
PEG | 78.32 |
Price to Sales | 0.51 |
Price to Book Ratio | 4.1 |
Enterprise Value to Revenue | 0.27 |
Enterprise Value to EBIT | 31.93 |
Enterprise Value to Net Income | 22 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.22 |
No data
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...